AI assistant
InfuSystem Holdings, Inc — Director's Dealing 2022
May 17, 2022
33639_dirs_2022-05-17_46210d01-14e5-4504-b789-ccd88c3d09ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InfuSystem Holdings, Inc (INFU)
CIK: 0001337013
Period of Report: 2022-05-17
Reporting Person: Steele Barry G (Executive VP and CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | Stock Option (right to buy) | $8.58 | A | 19995 | Acquired | 2032-05-17 | Common Stock (19995.0) | Direct |
| 2022-05-17 | Restricted Stock Units | $ | A | 13636 | Acquired | Common Stock (13636.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 22762 | Direct |
Footnotes
F1: This total includes an additional 1,959 shares acquired recently through the Company's Employee Stock Purchase Plan
F2: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant.
F3: The option, representing the right to purchase a total of 19,995 shares of InfuSystem Holdings, Inc. common stock, vests in three equal annual installments beginning May 17, 2023.
F4: Restricted stock units convert into common stock on a one-for-one basis.
F5: These restricted stock units will cliff vest on May 17, 2025.